Literature DB >> 26764187

Performance of ultrasound-based endometriosis staging system (UBESS) for predicting level of complexity of laparoscopic surgery for endometriosis.

U Menakaya1,2, S Reid3, C Lu4, B Gerges1, F Infante1, G Condous1,5.   

Abstract

OBJECTIVE: To develop and assess the performance of a preoperative ultrasound-based endometriosis staging system (UBESS) to predict the level of complexity of laparoscopic surgery for endometriosis.
METHODS: This was a multicenter prospective and retrospective cohort study on consecutive women with suspected endometriosis who underwent laparoscopy between June 2009 and July 2013. Each woman underwent a systematic transvaginal ultrasound evaluation to assess the pelvis for different phenotypes of endometriosis, and the diagnostic performance of ultrasound for these different phenotypes was evaluated relative to the gold standard, laparoscopy. A three-stage preoperative UBESS was developed to assess the severity of pelvic endometriosis, based on the histological phenotypes of endometriosis, the anatomical locations of deep infiltrating endometriosis and their sonographic markers of local invasiveness. The three stages of UBESS (I-III) were then correlated with the three levels of complexity of laparoscopic surgery for endometriosis described by the Royal College of Obstetricians and Gynaecologists (Levels 1-3). The end-points were the diagnostic performance of UBESS to predict the level of complexity of laparoscopic surgery for endometriosis, i.e. UBESS stage I to predict Level-1 laparoscopic surgery, UBESS stage II to predict Level-2 laparoscopic surgery and UBESS stage III to predict Level-3 laparoscopic surgery.
RESULTS: The analysis included 192 women, with a mean ± SD age at diagnosis of endometriosis of 23.7 ± 9.3 years and a mean duration of symptoms prior to presentation of 42 months. Predominant reported locations of pelvic pain were left iliac fossa (32%), right iliac fossa (29.5%) and lower abdomen (61%) and predominant symptoms included dyspareunia (57.5%), dysmenorrhea (58.5%) and dyschezia (41.5%). The accuracy, sensitivity, specificity, positive and negative predictive values and positive and negative likelihood ratios of UBESS I for predicting a requirement for Level-1 laparoscopic surgery were: 87.5%, 83.3%, 91.7%, 90.9%, 84.6%, 10 and 0.182; those of UBESS II for predicting Level-2 surgery were: 87.0%, 73.7%, 90.3%, 65.1%, 93.3%, 7.6 and 0.292; and those of UBESS III for predicting Level-3 surgery were: 95.3%, 94.8%, 95.5%, 90.2%, 97.7%, 21.2 and 0.054, respectively.
CONCLUSION: UBESS could be utilized to predict the level of complexity of laparoscopic surgery for endometriosis. It has the potential to facilitate the triage of women with suspected endometriosis to the most appropriate surgical expertise required for laparoscopic endometriosis surgery. UBESS needs to be validated externally in multiple centers to assess its general applicability.
Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  endometriosis; laparoscopy; preoperative staging; transvaginal ultrasound

Mesh:

Year:  2016        PMID: 26764187     DOI: 10.1002/uog.15858

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  9 in total

1.  ENDO_STAGE Magnetic Resonance Imaging: Classification to Screen Endometriosis.

Authors:  Marc Bazot; Emile Daraï; Giuseppe P Benagiano; Caroline Reinhold; Amelia Favier; Horace Roman; Jacques Donnez; Sofiane Bendifallah
Journal:  J Clin Med       Date:  2022-04-26       Impact factor: 4.964

Review 2.  'Seeing is believing': arguing for diagnostic laparoscopy as a diagnostic test for endometriosis.

Authors:  Jason Mak; Mathew Leonardi; George Condous
Journal:  Reprod Fertil       Date:  2022-06-10

3.  ENDORECT: a preoperative score to accurately predict rectosigmoid involvement in patients with endometriosis.

Authors:  C Chattot; C Huchon; A Paternostre; J Du Cheyron; E Chouillard; A Fauconnier
Journal:  Hum Reprod Open       Date:  2019-04-03

4.  Endometriosis classification, staging and reporting systems: a review on the road to a universally accepted endometriosis classification.

Authors:  Nathalie Vermeulen; Mauricio S Abrao; Jon I Einarsson; Andrew W Horne; Neil P Johnson; Ted T M Lee; Stacey Missmer; John Petrozza; Carla Tomassetti; Krina T Zondervan; Grigoris Grimbizis; Rudy Leon De Wilde
Journal:  Hum Reprod Open       Date:  2021-10-22

Review 5.  Brief Review of Endometriosis and the Role of Trace Elements.

Authors:  Ida Osuchowska-Grochowska; Eliza Blicharska; Marek Gogacz; Agata Nogalska; Izabela Winkler; Agnieszka Szopa; Halina Ekiert; Barbara Tymczyna-Borowicz; Mansur Rahnama-Hezavah; Cezary Grochowski
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

6.  Meta-analysis and systematic review to determine the optimal imaging modality for the detection of uterosacral ligaments/torus uterinus, rectovaginal septum and vaginal deep endometriosis.

Authors:  B Gerges; W Li; M Leonardi; B W Mol; G Condous
Journal:  Hum Reprod Open       Date:  2021-11-04

7.  Adenomyosis is an independent risk factor for complications in deep endometriosis laparoscopic surgery.

Authors:  Meritxell Gracia; Cristian de Guirior; Marta Valdés-Bango; Mariona Rius; Cristina Ros; Isabel Matas; Marta Tortajada; María Ángeles Martínez-Zamora; Lara Quintas; Francisco Carmona
Journal:  Sci Rep       Date:  2022-04-30       Impact factor: 4.996

8.  Endometriosis classification, staging and reporting systems: a review on the road to a universally accepted endometriosis classification.

Authors:  N Vermeulen; M S Abrao; J I Einarsson; A W Horne; N P Johnson; T T M Lee; S Missmer; J Petrozza; C Tomassetti; K T Zondervan; G Grimbizis; R L De Wilde
Journal:  Facts Views Vis Obgyn       Date:  2021-12

9.  Endometriosis of the vesico-vaginal septum: a rare and unusual localization (case report).

Authors:  Yassir Ait Benkaddour; Affaf El Farji; Abderraouf Soummani
Journal:  BMC Womens Health       Date:  2020-08-14       Impact factor: 2.809

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.